Product information

From Health Canada

Current status:

Cancelled Pre Market

Current status date:

2021-04-09

Original market date: See footnote 1

Product name:

FLURAZEPAM 30MG CAPSULE

DIN:

02232657 Electronic product monograph is not available

Company:

LABORATOIRES CONFAB INC
4355 Boul. Sir Wilfrid Laurier
St-Hubert
Quebec
Canada J3Y 3X3

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Targeted (CDSA IV)

 

American Hospital Formulary Service (AHFS): See footnote 3

28:24.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N05CD01 FLURAZEPAM

Active ingredient group (AIG) number:See footnote5

0108704001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
FLURAZEPAM HYDROCHLORIDE 30 MG / CAP
Version 4.0.3

"Page details"

Date modified: